FDA Proposes Framework to Advance Credibility of AI Models Used for Drug and Biological Product Submissions

The FDA issued draft guidance to provide recommendations on the use of artificial intelligence (AI) intended to support a regulatory decision about a drug or biological product’s safety, effectiveness or quality.
Source: FDA Press Releases

Leave a Comment





This site uses Akismet to reduce spam. Learn how your comment data is processed.